Prospective, multicenter non comparative and observational study (post-market clinical follow-up).
Patients operated with PASS OCT® manufactured by MEDICREA® INTERNATIONAL between July 2016 and July 2017.
The inclusion period will be 12 months and the follow-up 24 months
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient with
* degenerative disc disease or,
* spondylolisthesis, or
* spinal stenosis, or
* trauma, or
* atlanto-axial fractures with instability or
* cervical tumors.
* Patient operated with PASS OCT®
* Patient \> 18 years
* Patient affiliated to health care insurance (social security in France)
* Patient able to complete a self-administered questionnaire
* Patient able to understand the protocol and the planning visit
* Patient able to sign an informed consent form
Exclusion Criteria:
* Patient unable or unwilling to sign an informed consent form
* Patient unable to complete a self-administered questionnaire
* Pregnant patient or intending to get pregnant within the next 3 years
* Patient judged as non-compliant by the investigator or not able to come back for follow-up visits